Home/Filings/4/0000059478-22-000028
4//SEC Filing

Norton Johna 4

Accession 0000059478-22-000028

CIK 0000059478other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:59 PM ET

Size

11.4 KB

Accession

0000059478-22-000028

Insider Transaction Report

Form 4
Period: 2022-02-01
Norton Johna
Senior VP, Global Quality
Transactions
  • Tax Payment

    Common Stock

    2022-02-01$245.39/sh1,194$292,99626,946 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-02-012,6760 total
    From: 2022-02-01Exp: 2022-02-01Common Stock (2,676 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-01+2,67628,140 total
Holdings
  • Common Stock

    (indirect: by partner)
    128
  • Common Stock

    (indirect: By 401(k))
    2,675
  • Common Stock

    (indirect: By 401(k))
    514
Footnotes (2)
  • [F1]Reporting person disclaims beneficial ownership of these shares.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001702471

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:59 PM ET
Size
11.4 KB